USHER SYNDROME, TYPE 1B
Clinical trials for USHER SYNDROME, TYPE 1B explained in plain language.
Never miss a new study
Get alerted when new USHER SYNDROME, TYPE 1B trials appear
Sign up with your email to follow new studies for USHER SYNDROME, TYPE 1B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy for rare Blindness-Deafness syndrome passes early safety check
Disease control OngoingThis phase 2 study follows 9 adults with Usher syndrome type 1B who previously received a single injection of the gene therapy SAR421869 under their retina. Researchers are monitoring long-term safety and whether the treatment can slow retinal degeneration. The trial is active bu…
Matched conditions: USHER SYNDROME, TYPE 1B
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingThis study offers voluntary screening for newborns in North Carolina to detect a wide range of rare health conditions early. Using a small blood sample already collected at birth, the program tests for dozens of disorders, including spinal muscular atrophy, cystic fibrosis, and m…
Matched conditions: USHER SYNDROME, TYPE 1B
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 02, 2026 02:00 UTC